Retifanlimab with bevacizumab and hypofractionated radiotherapy to treat recurrent glioblastoma.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Nishika Karbhari, Angela Ulrich, Wendy Joyce Sherman, Susan Michelle Geyer, Shannon Patricia Fortin Ensign, Milan G. Chheda, Roy E. Strowd, Michael W. Ruff, Sani Haider Kizilbash, Ugur Sener, Joon H. Uhm, Bryan Neth, Evanthia Galanis, Eric J. Lehrer, William Breen, Elizabeth Yan, Anita Mahajan, Paul D. Brown, Jian Li Campian
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Incyte
OpenAlex ID: W4410819138